Neurim Pharmaceuticals Competitors and Similar CompaniesClear all

Neurim Pharmaceuticals's competitors and similar companies include Azevan Pharmaceuticals, Evecxia Therapeutics, NLS Pharmaceutics and CholesteniX.
Neurim Pharmaceuticals
Neurim Pharmaceuticals
Neurim Pharmaceuticals is a drug discovery and development company that focuses on the central nervous system (CNS) disorders.
Azevan Pharmaceuticals
Azevan Pharmaceuticals
Azevan Pharmaceuticals is a company specializing in therapeutics for stress-related CNS disorders and neurodegenerative conditions.
Evecxia Therapeutics
Evecxia Therapeutics
Evecxia Therapeutics is a clinical stage pharmaceutical company.
NLS Pharmaceutics
NLS Pharmaceutics
NLS Pharmaceutics is a biopharmaceutical company engaged in drug discovery for central nervous system disorders.
CholesteniX
CholesteniX
CholesteniX is a company specializing in cholesterol metabolites and oxysterols in neurodegeneration.
Founding Date
Founding Date
1991
Founding Date
1999
Founding Date
N/A
Founding Date
2019
Founding Date
2013
Type
Type
Private
Type
Private
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Tel Aviv-Yafo, IL HQ
Zug, CH
Locations
Bethlehem, US HQ
Locations
Durham, US HQ
Locations
Stans, CH HQ
Locations
Sketty, GB HQ
Employees
Employees
20
Employees
8
Employees
4
Employees
6
Employees
5
For sources of this data, please see the company profile

View Company Profiles

Azevan Pharmaceuticals
HQ
Bethlehem, US
Employees
8

Azevan Pharmaceuticals is a company specializing in therapeutics for stress-related CNS disorders and neurodegenerative conditions.

View company
Evecxia Therapeutics
HQ
Durham, US
Employees
4

Evecxia Therapeutics is a clinical stage pharmaceutical company.

View company
NLS Pharmaceutics
HQ
Stans, CH
Employees
6

NLS Pharmaceutics is a biopharmaceutical company engaged in drug discovery for central nervous system disorders.

View company
CholesteniX
HQ
Sketty, GB
Employees
5

CholesteniX is a company specializing in cholesterol metabolites and oxysterols in neurodegeneration.

View company